scispace - formally typeset
M

Mark W. Tibbitt

Researcher at ETH Zurich

Publications -  88
Citations -  8018

Mark W. Tibbitt is an academic researcher from ETH Zurich. The author has contributed to research in topics: Self-healing hydrogels & Medicine. The author has an hindex of 31, co-authored 74 publications receiving 6232 citations. Previous affiliations of Mark W. Tibbitt include Howard Hughes Medical Institute & University of Zurich.

Papers
More filters
Journal ArticleDOI

Light activated cell migration in synthetic extracellular matrices.

TL;DR: This work presents a strategy for manipulating individual mammalian stem cells in defined synthetic hydrogels through selective optical activation of Rac, which is an intracellular signaling protein that plays a key role in cell migration.
Journal ArticleDOI

Thermal Stabilization of Biologics with Photoresponsive Hydrogels

TL;DR: Hydrogel encapsulation improved stability for encapsulated enzymes commonly used in molecular biology (β-galactosidase, alkaline phosphatase, and T4 DNA ligase) following thermal stress, demonstrating a general method to employ reversible polymer networks as robust excipients for thermal stability of complex biologics during storage and shipment that additionally enable on-demand release of active molecules at the point of use.
Journal ArticleDOI

Human Retinal Microvasculature-on-a-Chip for Drug Discovery

TL;DR: A tunable organ‐on‐a‐chip model of the retinal microvasculature using human retinalmicrovascular endothelial cells with integrated flow will enable improved understanding of BRB biology and provide an additional tool for drug discovery.
Journal ArticleDOI

Immunofunctional photodegradable poly(ethylene glycol) hydrogel surfaces for the capture and release of rare cells

TL;DR: A patterned, immunofunctional, photodegradable PEG hydrogel capture surface is introduced for the isolation and selective release of rare cell populations and provides a micropatternable, cytocompatible platform that imparts the unique ability to recover pure, viable CTC samples by selectively releasing target cells.